Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infectionsIldikó Földi, Mária Papp, Tamás Tornai et al.|Liver International|2017Cited by 27
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortalityDávid Tornai, Péter Antal‐Szalmás, Tamás Janka et al.|Clinics and Research in Hepatology and Gastroenterology|2021Cited by 12
P0174 : Soluble CD163 (SCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortalityTamás Tornai, Mária Papp, Dávid Tornai et al.|Journal of Hepatology|2015Cited by 1
Su1490 Serum Levels of Lectin Complement Pathway Molecules Do Not Primarily Determine the Risk of Bacterial Infections in Patients With CirrhosisIldikó Földi, Mária Papp, Dávid Tornai et al.|Gastroenterology|2016Cited by 0
Serum Levels of Lectin Complement Pathway Molecules do not Predominantly Determine the Risk of Bacterial Infections in Patients with CirrhosisIldikó Földi, M Papp, Dávid Tornai et al.|Journal of Hepatology|2016Cited by 0